A phase II study of docetaxel (taxotere) in combination with cisplatin in patients with metastatic (stage IV) or unresectable (stage IIIB) localized non-small cell lung cancer (NSCLC)
2000 ◽
Vol 29
(1)
◽
pp. 84
H.K Kim
◽
K.S Lee
◽
J.S Kim
◽
Y.K Kim
◽
H.S Park
◽
...